Effectiveness of Empagliflozin on Cardiac-renal Injury in Patients With Acute ST-segment-elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention.
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Empagliflozin (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
Most Recent Events
- 24 Jul 2018 New trial record